Headline: MedPlus Health Services Faces Temporary Drug License Suspension

MedPlus Health Services Limited has reported a significant update regarding its subsidiary, Optival Health Solutions Private Limited. On October 31, 2025, the company received a suspension order for the drug license of one of its stores located in Devi Chowk, Rajamahendravaram, Andhra Pradesh. This decision was issued by the District Sales Licensing Authority as part of regulatory compliance under the Drugs and Cosmetics Act, 1940.

The suspension, which is set for seven days, could potentially lead to a revenue loss of approximately ₹1.75 lakhs for the affected store. This regulatory action falls under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, requiring timely communication to stakeholders.

MedPlus Health Services ensures transparency by making this information available on their official website, www.medplusindia.com, as well as on the websites of BSE Limited and the National Stock Exchange of India (NSE).

The company remains committed to compliance and is taking the necessary steps to address the situation. Investors and stakeholders can monitor updates through official channels as MedPlus navigates this temporary setback.

For further information, visit [MedPlus Health Services](http://www.medplusindia.com) or check the latest updates on [BSE](http://www.bseindia.com) and [NSE](http://www.nseindia.com).

Stay tuned to Smart Finance Saga for the latest financial news and analysis.